Ashwagandha Clinical Research: What Human Studies Show

Few herbs attract as many bold claims as ashwagandha. Shelves are full of bottles promising calm, deeper sleep and stronger workouts. But what does ashwagandha clinical research actually show when we set marketing aside and read the trials themselves?

The answer is more interesting, and more measured, than most labels suggest. Over the past two decades, researchers have run dozens of randomized trials in people, and several systematic reviews have pooled them. Together they give us a real picture of where the root extract helps, where results are thin, and where questions remain.

This page walks through that picture step by step, so you can judge the science yourself. We cover who was studied, which doses were used, how long trials ran and what changed. By the end, you will know which claims are well supported, which are still early, and how to read any new study with a sharper eye.

Executive Evidence Summary

Here is the short version for readers who want the conclusion first. The strongest findings sit in three areas: perceived stress and anxiety, sleep quality, and muscle strength in trained or untrained adults.

• Stress and anxiety: Several placebo-controlled trials, plus meta-analyses, report lower stress scores and often lower morning cortisol. Effects are usually moderate, and most trials are small.
• Sleep: Pooled data suggest a small-to-moderate improvement in sleep quality, with clearer signals in people with insomnia.
• Strength and recovery: Small trials in men report gains in strength and muscle size versus placebo. Women and older groups are far less studied.
• Hormones and fertility: Results are mixed. Some trials report higher testosterone or sperm quality, while others find no clear change.
• Safety: Most trials report few adverse events, yet rare liver injury cases have been published, so caution is warranted.

In short, the ashwagandha evidence is encouraging but not conclusive. Trial quality is uneven, samples are small, and many studies used branded extracts supplied by manufacturers.

The Research Question Behind Ashwagandha Human Studies

The guiding question is simple: in people, does standardized Withania somnifera root or root-and-leaf extract change measurable health outcomes more than placebo, and at what dose and duration? We also ask how safe it is and how consistent the results are across trials.

This question matters because animal and lab work cannot predict human results on its own. Only controlled trials in people can tell us whether an effect is real, large enough to notice, and worth the risk.

Search and Inclusion Methodology

To keep this review transparent, we describe the rules used to select studies.

• Sources: PubMed and major systematic review databases, plus the reference lists of recent meta-analyses.
• Included: Randomized, placebo-controlled trials in human adults that tested ashwagandha alone, reported a defined dose, and measured a clinical or validated outcome.
• Excluded: Animal and cell studies, multi-herb formulas where ashwagandha could not be isolated, case reports used as efficacy proof, and trials without a control group.
• Weighting: Meta-analyses and larger, better-controlled trials carry more weight than single small studies.

This is a narrative evidence review, not a new meta-analysis. It summarizes published work and does not replace a full registered systematic review.

Ashwagandha Evidence by Health Outcome

Stress and cortisol

Stress is the best-studied outcome. In a widely cited 60-day trial of 64 adults with chronic stress, 300 mg of a full-spectrum root extract twice daily lowered perceived stress scores and serum cortisol more than placebo. Another 60-day trial of 60 adults, using 240 mg of a standardized extract once daily, reported lower anxiety scores and lower cortisol. A dose-ranging trial of 98 adults found improvements across several doses of a root-and-leaf extract.

The direction of effect is consistent. The weak point is that cortisol is a changeable marker, and a lower level does not always mean a person feels better.

Anxiety

A systematic review of five trials found that most reported greater symptom relief with ashwagandha than placebo. A later meta-analysis of about a dozen trials also found lower anxiety and stress scores. Participants were mostly adults with mild-to-moderate symptoms, not clinical anxiety disorders, so the results should not be applied to severe illness.

Sleep and insomnia

Trials in healthy adults and in adults with insomnia, using about 600 mg daily for 8 to 10 weeks, reported faster sleep onset and better sleep quality scores. A meta-analysis of five trials involving roughly 400 people found a small-to-moderate benefit, strongest in those with insomnia and at doses of 600 mg or more.

Muscle strength and exercise

An 8-week trial of 57 young men reported larger gains in bench press, leg extension and muscle size with ashwagandha during resistance training. A meta-analysis of exercise trials found improvements in strength and oxygen uptake, though samples were small and mostly male.

Testosterone, fertility and cognition

In a trial of 43 overweight men aged 40 to 70, DHEA-S rose while the testosterone change fell short of statistical significance. Small studies in men with low sperm counts reported better semen quality. For memory, one 8-week trial of 50 adults with mild cognitive complaints reported gains on several tests. These areas have fewer trials, so confidence is lower.

Ashwagandha Human Studies Table: Key Trials at a Glance

The table lists representative randomized, placebo-controlled trials. Figures are summarized from the published papers and rounded; check the original paper before quoting exact numbers.

Trial (year)	Participants	Dose and form	Length	Primary endpoint	Main result
Auddy (2008)	98 adults, chronic stress	125, 250 or 500 mg/day root-and-leaf extract	60 days	Stress scale	Improved versus placebo
Chandrasekhar (2012)	64 adults, chronic stress	300 mg twice daily root extract	60 days	Perceived Stress Scale	Large drop in stress; lower cortisol
Lopresti (2019)	60 adults, mild anxiety	240 mg/day standardized extract	60 days	Anxiety rating scale	Lower anxiety and cortisol
Langade (2019)	60 adults, insomnia and healthy	300 mg twice daily root extract	10 weeks	Sleep onset and efficiency	Faster sleep onset; better efficiency
Wankhede (2015)	57 healthy young men	300 mg twice daily root extract	8 weeks	Muscle strength	Greater strength gains
Lopresti (2019, men)	43 overweight men, 40 to 70	21 mg withanolide glycosides/day	8 weeks	DHEA-S, testosterone	DHEA-S up; testosterone not significant
Choudhary (2017)	50 adults, mild cognitive impairment	300 mg twice daily root extract	8 weeks	Memory tests	Improved on several tests

Study Design Quality

Most trials in this table are randomized, double-blind and placebo-controlled, which is the right design for testing a supplement. That is a real strength.

Still, quality varies. Many report weak details on how participants were randomized or how blinding was kept. Sample sizes are small, often 40 to 100 people, so a few unusual results can swing the outcome. Few trials pre-registered their endpoints, which raises the risk that favorable outcomes were highlighted after the fact.

Participant Characteristics

Trial volunteers were mostly healthy or mildly affected adults aged about 18 to 65, and many were recruited in India. Studies of men outnumber studies of women. Older adults, adolescents, pregnant people and those with serious illness are rarely included. So the findings fit generally healthy adults best, and they should not be stretched to other groups.

Dose and Form Used

Doses ranged from about 240 mg to 1,000 mg of extract per day, often split into two servings. Forms differed too: some used root-only extracts, others used root-and-leaf blends, and each standardized withanolides differently. Because extracts are not interchangeable, a result for one branded product does not automatically carry over to another product on the shelf.

Duration of Trials

Most trials lasted 8 to 12 weeks. That is long enough to see changes in stress, sleep and strength, but too short to judge long-term benefit or safety. Very few trials followed participants after stopping, so we know little about whether effects last.

Primary Endpoints

The most common endpoints were validated questionnaires, such as the Perceived Stress Scale and anxiety rating scales, plus morning serum cortisol and sleep measures. Strength trials used direct tests like bench press. Questionnaires rely on self-report, which can be shaped by expectation, so blinding quality matters a great deal.

Results Across Ashwagandha Human Studies

Across the table, the active group usually beat placebo on stress, anxiety, sleep and strength. Reported improvements in stress scores ranged from modest to large, with the biggest figures coming from small, single-site trials. Hormone and cognition results were less uniform, and several secondary endpoints in each trial were not significant.

Clinical Significance: Do the Changes Matter?

A result can be statistically significant yet too small to feel. Many stress and anxiety changes in these trials are large enough on paper to matter, but the biggest ones come from small studies that tend to overstate effects. Sleep gains are real but modest. Strength gains were measurable in young men, though the benefit for athletes already well trained is unclear. A fair reading is "likely helpful for some people", not "proven for everyone".

Conflicts of Interest and Funding

Funding shapes how much trust a result deserves. Many ashwagandha trials were paid for, or supplied with product, by the companies that make the extract, and some authors are employees or consultants. That does not make the data false. It does mean independent replication matters, and it is a reason to treat positive branded-extract results with some caution. Always check the funding and disclosure sections of a paper.

Consistency Across Trials

Direction of effect is fairly consistent: trials on stress, anxiety and sleep mostly favor ashwagandha. Size of effect is not. Results vary with the extract, dose, population and outcome scale. Hormone, fertility and cognition findings are patchy. Consistency is good for stress, moderate for sleep and strength, and weak for other outcomes.

Meta-Analyses and Systematic Reviews

Pooling trials helps reduce the noise from small samples.

• Anxiety (review of 5 trials): Most trials favored ashwagandha, but the authors noted limited quality and small samples.
• Stress and anxiety (meta-analysis of about 12 trials): Significant reductions in stress and anxiety scores, with some heterogeneity.
• Sleep (meta-analysis of 5 trials, about 400 people): Small-to-moderate improvement in sleep quality, stronger in insomnia.
• Exercise performance (meta-analysis): Gains in strength and aerobic capacity, based on small studies.

These reviews agree with the single trials, but they inherit the same flaws: small samples, short durations and possible bias.

Ashwagandha Evidence Grading

The grades below are our own plain-language judgment of certainty, not an official rating.

Outcome	Number and size of trials	Consistency	Evidence grade
Perceived stress and cortisol	Many small trials, plus meta-analysis	Good	Moderate
Anxiety (mild to moderate)	Several trials, plus meta-analysis	Good	Moderate
Sleep quality and insomnia	Several trials, plus meta-analysis	Moderate	Low to moderate
Muscle strength	Few small trials, mostly men	Moderate	Low to moderate
Testosterone and fertility	Few small trials	Mixed	Low
Cognition and memory	Very few trials	Limited	Low
Long-term safety	Short trials, case reports	Limited	Low

Limitations of the Current Evidence

• Small samples and short follow-up limit confidence.
• Branded extracts differ, so results do not transfer cleanly between products.
• Many studies were funded by manufacturers.
• Self-reported outcomes are open to placebo effects.
• Underrepresented groups, including women, older adults and people with medical conditions, are poorly studied.
• Rare liver injury cases, mostly resolving after stopping, have been reported. People with liver disease, thyroid conditions, autoimmune disease or pregnancy, and anyone taking sedatives or thyroid medicine, should speak with a clinician first.

Bottom Line on Ashwagandha Clinical Research

Put simply, the human trials support ashwagandha as a plausible aid for stress, mild anxiety and sleep in healthy adults, with weaker support for strength and little for other claims. The signal is promising, yet the studies are small, short and often industry-funded.

So what should you do next? Read the original papers behind any product claim, check which extract and dose were tested, and talk with a doctor or pharmacist before starting, especially if you take medicine or have a health condition. Share this page with anyone weighing the evidence, and revisit it as larger, independent trials appear.

This article is educational and is not medical advice.

References

Please verify each citation against PubMed before publishing; details are given from the published literature as recalled.

1. Auddy B, et al. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans. J Am Nutraceutical Assoc. 2008.
2. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012.
3. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract. Medicine (Baltimore). 2019.
4. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and safety of ashwagandha root extract in insomnia and anxiety. Cureus. 2019.
5. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Beneficial effects of Withania somnifera on muscle mass and strength in resistance training. J Int Soc Sports Nutr. 2015.
6. Lopresti AL, Drummond PD, Smith SJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males. Am J Mens Health. 2019.
7. Choudhary D, Bhattacharyya S, Bose S. Efficacy and safety of ashwagandha root extract in improving memory and cognitive functions. J Diet Suppl. 2017.
8. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results. J Altern Complement Med. 2014.
9. Akhgarjand C, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis. Phytother Res. 2022.
10. Cheah KL, et al. Effect of ashwagandha on sleep: a systematic review and meta-analysis. PLoS One. 2021.
11. Bonilla DA, et al. Effects of ashwagandha on physical performance: systematic review and meta-analysis. J Funct Morphol Kinesiol. 2021.
12. Björnsson HK, et al. Drug-induced liver injury due to ashwagandha. Liver Int. 2020.